Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Platelet Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Post-approval studies (Phase 4)UnknownNCT03150667
What this trial is testing

Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD

Who this might be right for
Chronic Kidney DiseasesAcute Coronary Syndrome
North Texas Veterans Healthcare System 220
Post-approval studies (Phase 4)UnknownNCT01869309
What this trial is testing

Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor

Who this might be right for
Coronary Artery Disease
LifeBridge Health 400
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Not applicableStudy completedNCT01134679
What this trial is testing

(EASY)-IMProving Adherence to Clopidogrel Trial (IMPACT))

Who this might be right for
Coronary Artery Disease
Laval University 300
Large-scale testing (Phase 3)UnknownNCT01385319
What this trial is testing

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Who this might be right for
Coronary Artery Disease
Marco Valgimigli 1,606
Not applicableStudy completedNCT01175200
What this trial is testing

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.

Who this might be right for
Anti Platelet Effects
Ascopharm Groupe Novasco 82
Large-scale testing (Phase 3)Study completedNCT01813435
What this trial is testing

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Who this might be right for
Coronary Artery Disease (CAD)
ECRI bv 15,991
Large-scale testing (Phase 3)Ended earlyNCT00322543
What this trial is testing

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Who this might be right for
Coronary Disease
Conor Medsystems 3
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Post-approval studies (Phase 4)Ended earlyNCT03224923
What this trial is testing

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Who this might be right for
Stable Coronary SyndromePercutaneous Coronary InterventionAntiplatelet Therapy+1 more
Ottawa Heart Institute Research Corporation 5
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Post-approval studies (Phase 4)Ended earlyNCT01452152
What this trial is testing

Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study

Who this might be right for
Cardiovascular DiseasesAcute Coronary Syndrome
University of Maryland, Baltimore 9
Early research (Phase 1)Study completedNCT00768391
What this trial is testing

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Who this might be right for
Solid Tumors
Eli Lilly and Company 20
Not applicableStudy completedNCT05877027
What this trial is testing

Exercise vs. Topical Diclofenac vs. PRP

Who this might be right for
Gonarthrosis
Istanbul University - Cerrahpasa 82
Post-approval studies (Phase 4)Ended earlyNCT00239733
What this trial is testing

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

Who this might be right for
ThrombocytopeniaHepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126
Post-approval studies (Phase 4)UnknownNCT01643031
What this trial is testing

Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel

Who this might be right for
Diabetes MellitusCoronary Disease
Rabin Medical Center 500
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Post-approval studies (Phase 4)Study completedNCT02383771
What this trial is testing

Reversal of the Anti-platelet Effects of Ticagrelor

Who this might be right for
Coronary Artery Disease
The First Affiliated Hospital with Nanjing Medical University 64
Next Page